PLSM News & Events

Pulsenmore Ltd. Ordinary Shares trading halted, volatility trading pause

Pulsenmore announced a new commercial engagement with TLC Perinatal PA, a maternal-fetal medicine and women's ultrasound practice in Maryland, as part of its growing U.S. rollout. In early February Pulsenmore, through its U.S. subsidiary, entered into a services agreement with TLC Perinatal PA, which operates in Silver Spring and Germantown, Maryland. Under the agreement, TLC Perinatal will incorporate Pulsenmore's Early Screening home ultrasound services into its care model, allowing patients to perform ultrasound scans at home as part of a physician-directed hybrid care pathway that incorporates telehealth and scheduled in-clinic visits. TLC Perinatal is a specialized maternal-fetal medicine practice focused on diagnostic imaging and consultative care for pregnancies.

Pulsenmore announced a first commercial engagement with a medical center in the U.S., following receipt of FDA approval for its home pregnancy ultrasound product. At the end of January 2026, the Company entered into a services agreement with the Center for Fetal Medicine & Women's Ultrasound, a fetal medicine and women's ultrasound center located in LA California, or CFFM. Under the agreement, CFFM will purchase Pulsenmore ES home ultrasound services, enabling patients to benefit from remote monitoring while reducing unnecessary visits to the diagnostic center. Elazar Sonnenschein, CEO of Pulsenmore, commented: "This agreement will enable the deployment of a remote pregnancy monitoring model that places the patient and her needs at the center of care. This collaboration allows us to begin operating in a gradual and responsible manner in a market where many women face limited access to obstetric healthcare services, and to demonstrate how home-based ultrasound can become an integral part of routine medical care."